false 0001386301 0001386301 2025-11-12 2025-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report:

(Date of earliest event reported)

 

November 12, 2025

 

 

 

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other Jurisdiction of Incorporation)

 

1-39256

  11-3797644
(Commission File Number)   (IRS Employer Identification No.)

 

N/A1

(Address of Principal Executive Offices and zip code)

 

(310) 477-0354

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol(s) Name of each Exchange on which registered
Common stock, $0.001 par value RSSS The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

1 In November 2019, we became a fully remote company. Accordingly, we do not currently have principal executive offices. Our mailing address is 10624 E. Eastern Ave., Ste. A-614, Henderson, NV 89052.

 

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

The Registrant held its annual meeting of stockholders on November 12, 2025. At the annual meeting, there were 32,821,783 shares of the Registrant’s common stock entitled to vote, and 24,873,088 (75.78%) were represented at the annual meeting in person and by proxy. The following summarizes vote results for those matters submitted to the Registrant’s stockholders for action at the annual meeting:

 

1. Proposal to elect six members of the Registrant’s Board of Directors.

 

Director  For  Withheld
Barbara J. Cooperman  17,846,193  87,522
Kenneth L. Gayron  17,710,590  223,125
General Merrill McPeak  17,148,886  784,829
Jeremy Murphy  17,467,145  466,570
Roy W. Olivier  17,697,639  236,076
John Regazzi  17,517,035  416,680

 

2. Proposal to ratify the appointment of Wipfli LLP as the Registrant’s independent accountants for the year ending June 30, 2026.

 

For  Against  Abstain
24,841,816  20,420  10,852

 

3.Proposal to hold a non-binding advisory vote approving the following resolution endorsing the Registrant’s executive compensation: “RESOLVED, that the stockholders approve the compensation of the Company’s executives, as disclosed in the compensation tables and related narrative disclosure in the Company’s proxy statement for the Annual Meeting.”

 

For  Against  Abstain  Broker Non-Votes
17,844,026  26,733  62,956  6,939,373

 

4. Proposal to hold a non-binding advisory vote on whether an advisory vote on executive compensation should be held every 1 year, 2 years or 3 years.

 

1 Year  2 Year  3 Year  Abstain
17,832,593  1,557  78,131  21,434

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 RESEARCH SOLUTIONS, INC.
   
Date: November 13, 2025 By: /s/ William Nurthen
   William Nurthen
   Chief Financial Officer